A&E Medical (Alto Development Corporation) a global surgical implant company, has named Eric Sklar as CEO, effective immediately. He will succeed former CEO Michael Janish, who will resume his role as board chairman.
 
Sklar previously served as president of A&E Medical since 2015, where he was instrumental in the recruitment and execution of acquiring Medical Concepts of Europe (MCE) and the purchase of the Cardiothoracic business unit from RTI Surgical (RTIX). Sklar has a track record of revitalizing and profitably growing global businesses within the healthcare industry. Prior to A&E Medical, Sklar held senior leadership roles where he improved the performance of business units at companies including Terumo Cardiovascular and Pall Corporation.
 
“Eric is a dynamic leader and has proven to be a great steward of the A&E organization over the past two years. A&E has seen strong growth and organizational development under Eric’s oversight and we’re excited about what the future holds with Eric as chief executive officer,” said Janish. “Eric has A&E on a great trajectory and the Board of Directors and I look forward to continuing to work with him in his new role.”
 
“I am honored to be appointed chief executive officer of A&E Medical. I look forward to continuing to work with our executive team and employees to provide world-class cardiac surgery products around the globe,” said Sklar.
 
Sklar earned an M.B.A. from Kellogg School of Management, Northwestern University, a masters of science degree from Eastern Michigan University and a bachelor of science degree from Michigan State University.
 
A&E Medical is a developer of cardiothoracic surgery, focused on sternal closure and dedicated to providing surgeons with a portfolio which includes a comprehensive sternal closure pipeline, pacing wires and an array of rotating surgical punches. A&E is headquartered in Farmingdale, N.J., and dedicated to serving surgeons, hospitals and patients.